Merck raises 2026 profit guidance, beats quarterly estimates
FRANKFURT: Germany’s Merck KGaA raised its 2026 core profit guidance and beat quarterly expectations on Thursday, helped by continued strong demand for semiconductor materials and drug production supplies.
The diversified family-controlled group said it expects adjusted earnings before interest, taxes, depreciation and amortisation (EBITDA) of between 5.9 billion euros and 6.3 billion euros ($6.8 billion-$7.3 billion) in 2026, up from previous guidance of between 5.7 billion euros and 6.1 billion euros.
